Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function

NCT07186062 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT07186062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07186062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases With Acute Decompensated Heart Failure With Impaired Renal Function
Lead sponsor
Ain Shams University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2022
Completion date
June 1, 2024
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute decompensated heart failure (adhf), cardiorenal syndrome (crs)